Forskolin (Diterpenoid)

Forskolin is a diterpenoid compound extracted from Coleus forskohlii root that activates adenylyl cyclase to increase cellular cAMP levels. This compound has been used in traditional Ayurvedic medicine, though clinical evidence for health benefits remains limited.

Origin & History

Forskolin is a labdane-type diterpenoid extracted from the roots of Coleus forskohlii (Plectranthus barbatus), a plant in the Lamiaceae family native to India. The compound is isolated through solvent extraction methods, with ethanol Soxhlet extraction yielding the highest content (up to 2.83% from dried roots), and can be purified to >99% purity through crystallization and charcoal treatment.

Historical & Cultural Context

While the research indicates Coleus forskohlii is used in Ayurvedic medicine and is native to India, specific traditional uses, indications, or historical context are not detailed in the available sources. The traditional medicine applications remain unspecified in the current research.

Health Benefits

• No clinical health benefits can be listed as the research dossier explicitly states there are no human clinical trials, RCTs, or meta-analyses available
• The dossier indicates forskolin is traditionally used in Ayurvedic medicine, though specific traditional applications are not detailed
• Without clinical evidence, health benefit claims cannot be substantiated from the provided research
• The compound has been isolated and purified to pharmaceutical standards (>99% purity), suggesting research interest
• Further clinical research is needed to establish evidence-based health benefits

How It Works

Forskolin directly activates adenylyl cyclase enzyme, bypassing G-protein coupled receptors to increase intracellular cyclic adenosine monophosphate (cAMP) levels. Elevated cAMP activates protein kinase A, which then phosphorylates various target proteins involved in metabolism and cellular signaling. This mechanism makes forskolin a valuable research tool for studying cAMP-dependent pathways.

Scientific Research

The research dossier explicitly states that search results lack details on human clinical trials, RCTs, or meta-analyses for forskolin. No PubMed PMIDs, study designs, sample sizes, or clinical outcomes are available in the current evidence base.

Clinical Summary

Currently, no human clinical trials, randomized controlled trials, or meta-analyses have been conducted on forskolin supplementation. The available research is limited to in vitro and animal studies examining its biochemical mechanisms. While forskolin has a well-established mechanism of action at the cellular level, clinical evidence for therapeutic benefits in humans is absent. Any health claims are based on traditional use rather than rigorous clinical evidence.

Nutritional Profile

Forskolin is a pure bioactive diterpenoid labdane compound (C22H34O7, molecular weight 410.5 g/mol) isolated primarily from the root of Coleus forskohlii (Plectranthus barbatus). It is not a nutritional ingredient and contains no meaningful macronutrients, micronutrients, vitamins, minerals, fiber, or protein in its isolated supplemental form. As a concentrated phytochemical extract, it is typically standardized to 10–20% forskolin content by weight in commercial root extracts (e.g., a 250 mg extract standardized to 10% yields 25 mg active forskolin per dose). The compound's primary biochemical identity is as a direct activator of adenylyl cyclase (adenylate cyclase), elevating intracellular cyclic adenosine monophosphate (cAMP) concentrations across multiple cell types. Bioavailability is limited by oral route delivery due to first-pass hepatic metabolism; lipophilic nature (logP approximately 2.5) facilitates membrane permeability. The crude Coleus forskohlii root additionally contains minor diterpenoid analogs (1,9-dideoxyforskolin, 9-deoxyforskolin, 1-deoxyforskolin) which lack meaningful adenylyl cyclase activity. No caloric value, glycemic contribution, or micronutrient density is attributable to forskolin as an isolated compound or standardized extract.

Preparation & Dosage

No clinically studied dosage ranges have been established according to the research dossier. The compound is available in standardized extracts containing 30% forskolin content, though human dosing guidelines are not provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic compounds identified in available research

Safety & Interactions

Safety data for forskolin supplementation is limited due to the lack of human clinical trials. Theoretical concerns exist regarding interactions with medications that affect blood pressure or heart rate, given forskolin's impact on cAMP signaling pathways. The compound may potentially interact with anticoagulant medications due to its effects on platelet function. Pregnant and breastfeeding women should avoid forskolin due to insufficient safety data.